{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:17:37Z","timestamp":1776377857993,"version":"3.51.2"},"reference-count":15,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:00:00Z","timestamp":1611446400000},"content-version":"unspecified","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,12,14]]},"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>This case report describes successful maintenance treatment with oral S-ketamine in a patient with severe depression, who previously was resistant to electroconvulsive therapy and deep brain stimulation, and who also had comorbid psychotic and obsessive compulsive symptoms.<\/jats:p>","DOI":"10.1136\/bcr-2020-238135","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T11:37:02Z","timestamp":1611574622000},"page":"e238135","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Oral S-ketamine effective after deep brain stimulation in severe treatment-resistant depression and extensive comorbidities"],"prefix":"10.1136","volume":"14","author":[{"given":"Jolien K E","family":"Veraart","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands"},{"name":"PsyQ Haaglanden, Parnassia Psychiatric Institute, The Hague, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanine","family":"Kamphuis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathis","family":"Schlegel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0760-9866","authenticated-orcid":false,"given":"Robert A","family":"Schoevers","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands"},{"name":"Research School of Behavioural and Cognitive Neurosciences (BCN), University of Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"2025082707500299000_14.1.e238135.1","doi-asserted-by":"crossref","unstructured":"Smith-Apeldoorn SY , Veraart JKE , Schoevers RA . Definition and epidemiology of treatment resistance in psychiatry. In: Kim YK , ed. Treatment resistance in psychiatry: risk factors, biology and management. Springer Nature Singapore Pte Ltd, 2019: 16\u201338.","DOI":"10.1007\/978-981-10-4358-1_1"},{"key":"2025082707500299000_14.1.e238135.2","first-page":"CD011612","article-title":"Ketamine and other glutamate receptor modulators for depression in adults","volume":"23","author":"Caddy","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025082707500299000_14.1.e238135.3","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18r12475","article-title":"Oral ketamine for depression: a systematic review","volume":"80","author":"Rosenblat","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"2025082707500299000_14.1.e238135.4","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.115.165498"},{"key":"2025082707500299000_14.1.e238135.5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamapsychiatry.2016.0152","article-title":"Deep brain stimulation of the ventral anterior limb of the internal capsule for treatment-resistant depression: a randomized clinical trial","volume":"73","author":"Bergfeld","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"2025082707500299000_14.1.e238135.6","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.150"},{"key":"2025082707500299000_14.1.e238135.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(01)00243-3"},{"key":"2025082707500299000_14.1.e238135.8","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.biopsych.2017.06.011","article-title":"Efficacy of Esketamine in the treatment of depression with psychotic features: a case series","volume":"83","author":"Ajub","year":"2018","journal-title":"Biol Psychiatry"},{"key":"2025082707500299000_14.1.e238135.9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2017.01.012","article-title":"Reply to: ketamine and psychosis history: antidepressant efficacy and psychotomimetic effects Postinfusion","volume":"82","author":"Medeiros da Frota Ribeiro","year":"2017","journal-title":"Biol Psychiatry"},{"key":"2025082707500299000_14.1.e238135.10","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/j.biopsych.2016.08.041","article-title":"Ketamine and psychosis history: antidepressant efficacy and psychotomimetic effects Postinfusion","volume":"82","author":"Pennybaker","year":"2017","journal-title":"Biol Psychiatry"},{"key":"2025082707500299000_14.1.e238135.11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/ph12030133","article-title":"The impact of childhood maltreatment on intravenous ketamine outcomes for adult patients with treatment-resistant depression","volume":"12","author":"O'Brien","year":"2019","journal-title":"Pharmaceuticals"},{"key":"2025082707500299000_14.1.e238135.12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.psychres.2014.07.056","article-title":"The associations among childhood maltreatment, \"male depression\" and suicide risk in psychiatric patients","volume":"220","author":"Pompili","year":"2014","journal-title":"Psychiatry Res"},{"key":"2025082707500299000_14.1.e238135.13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1237375"},{"key":"2025082707500299000_14.1.e238135.14","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/0269881120922955","article-title":"Effects of subcutaneous esketamine on blood pressure and heart rate in treatment-resistant depression","volume":"34","author":"Del Sant","year":"2020","journal-title":"J Psychopharmacol"},{"key":"2025082707500299000_14.1.e238135.15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14656566.2019.1683161","article-title":"Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder","volume":"21","author":"Kryst","year":"2020","journal-title":"Expert Opin Pharmacother"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-238135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:50:09Z","timestamp":1756306209000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-238135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,25]]},"published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1136\/bcr-2020-238135"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-238135","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}